-
CATALYST finds hypercortisolism present in nearly a quarter of patients with difficult-to-control type 2 diabetes
Study investigators believe their findings strongly highlight the need for improved hypercortisolism screening and treatment approaches in this patient population. Lead author John B. Buse, MD, PhD, said the knowledge that there is a potential secondary cause for difficult-to-control disease may benefit the mental and emotional health of both patients and their providers.
-
Experts explain potential of beta-cell replacement therapy for type 1 diabetes
Despite advances in blood glucose monitoring and insulin delivery, most people living with type 1 diabetes do not meet their glycemic targets. Experts including Anna Lam, MD, MSc, discussed treatment options to help address this gap in care.
Session Coverage
-
Symposium explores the ‘final frontier’ of implementation science in diabetes
Experts including Brian Oldenburg, MPsychol, PhD, discussed ongoing challenges to U.S. and global implementation of proven approaches to diabetes prevention and treatment and ways to overcome them.
-
Researchers discuss CNS and its role in systemic metabolism
The central nervous system is an essential element in a holistic model of glucose homeostasis, explained Zaman Mirzadeh, MD, PhD. Elevated glucose levels result in insulin release from beta cells, which are glucose sensing, and that has actions on various organs to restore euglycemia.
-
Panelists address cost, quality, and disparities in diabetes care
Osagie Ebekozien, MD, MPH, CPQH, and other experts outlined the ramifications of existing disparities in diabetes care, the importance of person-centered care, and the need for collaboration to improve patient outcomes.
-
Continuous glucose monitors, insulin pens, other technology transform diabetes care
New options for collecting timely, comprehensive blood glucose data facilitates real-time tracking of the effects of food, nutrition, and medication. Caitlin Nass, MSN, CRNP, and other panelists explain what real-world changes clinicians and patients living with diabetes experience.
-
Experts debate whether immune or beta cells precipitate progression of type 1 diabetes
Jamie L. Felton, MD, argued that immune cells precipitate disease advancement, while Edward Phelps, PhD, made the case that beta cells are a more influential factor.
-
Symposium outlines patient and economic perspectives of navigating pediatric type 1 diabetes
Amanda Twigg, MD, discussed being a parent with the disease whose child also has the disease and deciding whether to participate in clinical prevention trials.
Presenter Profiles
-
Presenter Profile: Molecular Integration of Amino Acid and Fat Metabolism in Health and Metabolic Disease
Phillip J. White, PhD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Monday, June 24, at 8:00 a.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Diabetes Genetic Convergence—Shared Networks of Rare and Common Variants
Yan Li, PhD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Monday, June 24, at 3:15 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.
-
Presenter Profile: Improving Culture of Quality in Pediatric Centers—Lessons from the Type 1 Diabetes Exchange Quality Improvement Collaborative
Anna Cymbaluk, MD, previews a presentation at the 84th Scientific Sessions. Attendees in Orlando can watch the session in-person Monday, June 24, at 3:15 p.m. ET, and select recordings will be available on the meeting’s virtual platform after the live presentations.